Homeopathic treatment of warts

Comparative effectiveness of high (above 12CH) and low (below 12CH) potencies of individualized homeopathic medicines in treatment of warts: A multi-centric, double-blind, randomized trial - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/055962

Enrollment

200

Registered

2023-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Individualized Homeopathic Medicines (IHMs) in lower potencies (6CH or 12CH) of centesimal scale: Intervention is planned as administering the indicated homeopathic medicines in desired

dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Study subjects will be advised to

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suffering from cutaneous warts (non-genital; 2020 ICD-10-CM diagnosis code B07.9) for variable periods of time and not taking any other treatment for those warts for at least 1 month. 2. Patients already undergoing treatment for warts were recruited only after having completely stopped that therapy and with a subsequent wash-out phase of 1 month or more 3. Those aged between 18 and 65 years 4. Participants of either sex 5. Literate patients who can read English, Hindi and/or Bengali. Illiterate patients will be interviewed by the investigators maintaining privacy

Exclusion criteria

Exclusion criteria: 1. Patients with anogenital and genital warts 2. Patients already taking any form of treatment or willing to continue so for warts 3. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant and puerperal women, lactating mothers 6. Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence 7. Self-reported immune-compromised state (e.g., HIV) 8. Undergoing homeopathic treatment for any chronic disease(s) within last 6 months 9. Simultaneous participation in any other clinical trial

Design outcomes

Primary

Measure	Time frame
The number & size of each wart (measured by a millimeter scale on its longest diameter)Timepoint: Baseline, every month, up to 6 months	—

Secondary

Measure	Time frame
Dermatology Life Quality Index (DLQI)Timepoint: Baseline, every month, up to 6 months	—

Countries

India

Contacts

Public ContactSubhranil Saha

D. N. De Homoeopathic Medical College and Hospital

drsubhranilsaha@hotmail.com8777382128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026